Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Larimar Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −4 vs. Q1 2022
- Shares held
- 14.4M
- −834.2K (−5.5%) vs. Q1 2022
- Total value
- $28.2M
- −$33.4M (−54.2%) vs. Q1 2022
- New holders
- 1
- 4 more added
- Sold out
- 5
- 14 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $291.4M |
| Q1 2026 | 162 | $394.8M |
| Q4 2025 | 136 | $277.0M |
| Q3 2025 | 136 | $274.8M |
| Q2 2025 | 116 | $180.1M |
| Q1 2025 | 103 | $131.9M |
| Q4 2024 | 116 | $245.5M |
| Q3 2024 | 123 | $421.3M |
| Q2 2024 | 107 | $473.5M |
| Q1 2024 | 104 | $482.8M |
| Q4 2023 | 69 | $179.6M |
| Q3 2023 | 65 | $153.0M |
| Q2 2023 | 65 | $120.2M |
| Q1 2023 | 69 | $174.2M |
| Q4 2022 | 48 | $160.1M |
| Q3 2022 | 59 | $123.9M |
| Q2 2022 | 40 | $28.2M |
| Q1 2022 | 45 | $61.8M |
| Q4 2021 | 49 | $157.2M |
| Q3 2021 | 54 | $167.5M |
| Q2 2021 | 45 | $142.8M |
| Q1 2021 | 57 | $206.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 213 | $0 | 0.00% | −116,010−99.8% | Reduced |
| Global Retirement Partners, LLC | 225 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Disciplined Investments, LLC | 116 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 78 | $0 | 0.00% | +78 | New |
| UBS Group AG | 601 | $1.00K | 0.00% | −1,132−65.3% | Reduced |
| Citigroup Inc | 275 | $1.00K | 0.00% | −111−28.8% | Reduced |
| US Bancorp | 1,175 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,262 | $2.00K | 0.00% | +47+3.9% | Added |
| Cutler Group LP | 1,200 | $2.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,004 | $4.00K | 0.00% | −97−4.6% | Reduced |
| Solstein Capital, LLC | 4,477 | $9.00K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 13,676 | $27.0K | 0.00% | +779+6.0% | Added |
| Bank of New York Mellon Corp | 18,973 | $37.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 21,330 | $42.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 22,712 | $45.0K | 0.00% | −5,700−20.1% | Reduced |
| Dimensional Fund Advisors LP | 24,738 | $48.0K | 0.00% | −3,400−12.1% | Reduced |
| Royce & Associates LP | 28,064 | $55.0K | 0.00% | 00.0% | Unchanged |
| Difesa Capital Management, LP | 34,550 | $68.0K | 0.05% | −17,500−33.6% | Reduced |
| State Street Corp | 41,450 | $81.0K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 49,996 | $98.0K | 0.03% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 51,606 | $100.0K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 113,890 | $223.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 121,599 | $238.0K | 0.01% | +58,799+93.6% | Added |
| Fi3 FINANCIAL ADVISORS, LLC | 121,818 | $239.0K | 0.20% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 175,542 | $344.0K | 0.00% | +2,800+1.6% | Added |
| Adage Capital Partners GP, L.L.C. | 176,680 | $346.0K | 0.00% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 210,500 | $413.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 242,108 | $475.0K | 0.00% | −3,748−1.5% | Reduced |
| 683 Capital Management, LLC | 248,800 | $488.0K | 0.04% | −1,200−0.5% | Reduced |
| Atlas Venture Advisors, Inc. | 292,184 | $573.0K | 0.18% | 00.0% | Unchanged |
| Verition Fund Management LLC | 403,890 | $792.0K | 0.02% | −20,709−4.9% | Reduced |
| Vanguard Group Inc | 511,082 | $1.00M | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 529,808 | $1.04M | 0.00% | −1760.0% | Reduced |
| Janus Henderson Group PLC | 749,068 | $1.48M | 0.00% | −296,177−28.3% | Reduced |
| Mangrove Partners | 867,812 | $1.70M | 0.13% | 00.0% | Unchanged |
| Opaleye Management Inc. | 932,814 | $1.83M | 0.82% | −10,888−1.2% | Reduced |
| Ra Capital Management, L.P. | 1,031,482 | $2.02M | 0.05% | −250,378−19.5% | Reduced |
| CHI Advisors LLC | 1,515,148 | $2.97M | 1.14% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 5,830,249 | $11.4M | 0.24% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −55,366−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,998−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |